Immunoreactive interleukin-6 and C-reactive protein in plasma cell disorders.
作者信息
Smith S R, Morgan L
出版信息
Br J Haematol. 1994 Aug;87(4):883-4. doi: 10.1111/j.1365-2141.1994.tb06765.x.
Abstract
摘要
相似文献
1
Immunoreactive interleukin-6 and C-reactive protein in plasma cell disorders.浆细胞疾病中的免疫反应性白细胞介素-6和C反应蛋白
Br J Haematol. 1994 Aug;87(4):883-4. doi: 10.1111/j.1365-2141.1994.tb06765.x.
2
Serum immunoreactive interleukin-6 and C-reactive protein levels in patients with multiple myeloma at diagnosis.多发性骨髓瘤患者诊断时的血清免疫反应性白细胞介素-6和C反应蛋白水平。
Br J Haematol. 1994 Feb;86(2):391-3. doi: 10.1111/j.1365-2141.1994.tb04748.x.
3
4
5
Clinical significance of elevated soluble interleukin-6 receptor levels in the sera of patients with plasma cell dyscrasias.浆细胞异常增殖性疾病患者血清中可溶性白细胞介素-6受体水平升高的临床意义
Br J Haematol. 1995 Sep;91(1):116-20. doi: 10.1111/j.1365-2141.1995.tb05255.x.
6
Serum neural cell adhesion molecule in multiple myeloma and other plasma cell disorders.
Br J Haematol. 1996 Jan;92(1):67-70. doi: 10.1046/j.1365-2141.1996.00277.x.
7
Diagnostic value of serum IL-6 level in monoclonal gammopathies.血清白细胞介素-6水平在单克隆丙种球蛋白病中的诊断价值
Br J Haematol. 1995 Feb;89(2):243-9. doi: 10.1111/j.1365-2141.1995.tb03296.x.
8
Serum oncostatin M in multiple myeloma: impact on disease severity and prognosis.多发性骨髓瘤中的血清抑瘤素M：对疾病严重程度和预后的影响。
Eur J Haematol. 2000 Jul;65(1):52-6. doi: 10.1034/j.1600-0609.2000.90167.x.
9
Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.白细胞介素6（一种有效的骨髓瘤细胞生长因子）的血清水平，可反映浆细胞异常增殖性疾病的疾病严重程度。
J Clin Invest. 1989 Dec;84(6):2008-11. doi: 10.1172/JCI114392.
10
Serum interleukin-11 in plasma-cell dyscrasias.
Am J Hematol. 1996 Nov;53(3):206-7. doi: 10.1002/1096-8652(199611)53:3<206::aid-ajh2830530302>3.0.co;2-r.
Zotero 插件